Resp Path Flashcards
- Symptoms: ** Lab Values: ** Pathophysiology: Lodges in lower portion of right inferior lobe. Right lung more common because right main stem bronchus is wider and more vertical than the left. Treatment: *
Inhaled foreign body while sitting up
- Symptoms: ** Lab Values: ** Pathophysiology: Lodges in superior potion of right inferior lobe. Right lung more common because right main stem bronchus is wider and more vertical than the left. Treatment: *
Inhaled foreign body while supine
- Symptoms: ** Lab Values: ** Pathophysiology: ** Treatment: *Nitrates to cause methemglobinemia, then thiosulfate to bind cyanide.
Cyanide poisoning
- Symptoms: ** Lab Values: ** Pathophysiology: *Oxidized (ferric, Fe3+) form that has low O2 affinity, but high cyanide affinity. * Treatment: *Methylene blue.
Methemgoblinemia
- Symptoms: ** Lab Values: Carboxyhemoglobinemia. Pathophysiology: Decreases hemoglobin’s oxygen bindign capacity (downward shift, lower Vmax) and decreases O2 unloading in tissues (left shift) Treatment: *
Carbon monoxide poisoning
- Symptoms: * Results in cyanosis and right heart failure (cor pulmonale). Seen in young females.* Lab Values: > 25 mmHg pressure in the pulmonary artery. Smooth muscle hypertrophy. Pathophysiology: . Normally functions to inhibit vascular smooth muscle proliferation; poor prognosis. Treatment: *
Primary pulmonary hypertension
- Symptoms: Athersclersois, medial hypertrophy, and intimial fibrosis. Results in cyanosis and right heart failure (cor pulmonale). Lab Values: > 25 mmHg pressure in the pulmonary artery. Pathophysiology: Due to COPD, mitral stenosis, recurrent thromboemboli, autoimmune disease (scleroderma), left-to-right shunting, sleep apenea, or living at high altitudes. Treatment: *
Secondary pulmonary hypertension
- Symptoms: ** Lab Values: ** Pathophysiology: Associated with long bone fractures and liposuction. Treatment: *
Fat embolus
- Symptoms: ** Lab Values: ** Pathophysiology: ** Treatment: *
Air embolus
- Symptoms: ** Lab Values: ** Pathophysiology: ** Treatment: *
Thrombus
- Symptoms: ** Lab Values: ** Pathophysiology: ** Treatment: *
Mycotic emboli
- Symptoms: ** Lab Values: ** Pathophysiology: Can lead to DIC, especially postpartum. Treatment: *
Amniotic fluid emboli
- Symptoms: Chest pain, tachypnea, dyspnea. Respiratory alkalosis. Lab Values: Diagnose via helical CT. Pathophysiology: Approximately 95% of pulmonary emboli arise in the deep leg veins. Treatment: *
Pulmonary embolism
- Symptoms: Can lead to pulmonary embolus. Lab Values: Hooman’s sign - tender calf muscle on dorsiflexion of the foot. Pathophysiology: Caused by stasis, hypercoagulability, or endothelial damage (Virchow’s triad). Treatment: *
Deep vein thrombosis
- Symptoms: Airways close prematurely at high lung volumes. Lab Values: ↑RV, ↓FVC, ↓↓FEV1, {{↓FEV1/FVC ratio (hallmark).}} Pathophysiology: V/Q mismatch. Treatment: *
Obstructive lung disease (COPD)
- Symptoms: “Blue bloater”. Wheezing, crackles, cyanosis (early-onset hypoxemia due to shunting), late-onset dyspnea. Productive cough for 3 months a year for 2 consecutive years. Lab Values: ↓FEV1/FVC ratio; Reid index > 50% (gland depth/total thickness of bronchial wall). Hypercapnia (high PaCO2, low PaO2). Pathophysiology: Typically an obese male smoker. Hypertrophy of mucus secreting glands in the bronchioles. Disease of the small airways. Tends to have squamous metaplasia (unlike asthma). Can lead to cor pulmonale. Treatment: *
Chronic bronchitis
- Symptoms: “Pink puffer”. Exhalation through pursed lips to ↑airway pressure and prevent airway collapse during respiration. Progressive dyspnea and weight loss. Lab Values: ↓FEV1/FVC ratio; {{barrel-shaped chest; ↑compliance; ↑elastase activity or alpha-1 antitrypsin deficiency}}. Pathophysiology: Typically a thin smoker (or air pollution).{{ Enlargement of air spaces and ↓recoil resulting from destruction of alveolar walls. }}Compliance increased due to loss of elastic fibers. Worse in the apical segments of upper lobes. Treatment: *
Centriacinar (centrolobular) emphysema
- Symptoms: Cough, wheezing, tachypnea, dyspnea, hypoxemia, pulsus paradoxus, mucus plugging (but no squamous metaplasia). Lab Values: ↓FEV1/FVC ratio; ↓I/E ratio (normal 1:2); {{dx with metacholine. Charcot-Leyden crystals}} (eosinophil membrane protein). {{Curschmann’s spirals}} (shed epilthelium from mucous plugs). Pathophysiology: {{Bronchial hyper-responsiveness}} causes reversible bronchoconstriction; smooth muscle hypertrophy. {{Type I hypersensitivity (pollen, dust, food, molds, animal dander).}} Treatment: *
Extrinsic asthma
- Symptoms: something blocks or causes a Chronic necrotizing infection of bronchi which leads to {{permanently dilated airways distal to obstruction, purulent sputum, recurrent recurrent infections, and hemopytsis}}. Increased risk of aspergillosis. Foul smelling sputum (if anaerobe involvement). Lab Values: ↓FEV1/FVC ratio Pathophysiology: {{Associated with bronchial obstruction, poor ciliary motility (smoking), Kartagener’s syndrome.}} Treatment: *
Bronchiectasis
- Symptoms: Lowered diffusing capacity due to pulmonary dysfunction. Lab Values: ↓FVC and TLC; {{↑ or normal FEV1/FVC ratio}} (> or = 80%). Pathophysiology: ARDS, neonatal respiratory distress syndrome, pneumoconioses (coal miner’s silicosis, abestosis), sarcoidosis, idiopathic pulmonary fibrosis, Goodpasture’s, Wegener’s, histiocytosis X, bleomycin/busulfan/amiodarone. Treatment: *
Restrictive lung disease due to interstital lung diseases
- Symptoms: Peripheral hypoventilation due to extrapulmonary dysfunction. Lab Values: ↓FVC and TLC; ↑ or normal FEV1/FVC ratio (> or = 80%). ↓compliance. Pathophysiology: Poor muscular effort (poliomyelitis, myasthenia gravis); poor structural apparatus (scoliosis, morbid obesity). Treatment: *
Restrictive lung disease due to poor breathing mechanics
- Symptoms: {{Involves upper lobes}}. Lab Values: * {{Restrictive}}↓FVC and TLC; ↑ or normal FEV1/FVC ratio (> or = 80%). {{“Eggshell” calcification of hilar lymph nodes. Birefringence on polarized light.}}* Pathophysiology: Restrictive lung disease. {{Associated with foundries, sandblasting, and mines. Macrophages response to silica and release fibrogenic factors, leading to fibrosis}}. Silica may distrupt phagolysosomes and increase susceptibilty to TB. Particles less than 10 microns in size (escape cilia). Treatment: *
Silicosis
- Symptoms: {{Involves lower lobes}}. Increased incidence of bronchogenic carcinoma and mesothelioma. Family members at increased risk of bronchogenic carcinoma because it’s on their clothing. Lab Values: * {{Restrictive}}↓FVC and TLC; ↑ or normal FEV1/FVC ratio (> or = 80%). “Ivory white” calcified pleural plaques. Positive Prussian blue stain (asbestos bodies may be coated with iron).* Pathophysiology: Restrictive lung disease. Associated with ship-building, break-lining, roofing, and plumbing. Particles less than 10 microns in size (escape cilia). Treatment: *
Asbestosis
- Symptoms: Acute exposure results in pneumonitis. Chronic exposure results in pulmonary noncaseating granulomas, fibrosis, hilar lymph node granulomas, and systemic noncaseating granulomas. Lab Values: {{Restrictive}}↓FVC and TLC; ↑ or normal FEV1/FVC ratio (> or = 80%). Pathophysiology: {{Associated with aerospace industry and nuclear reactors. Type IV hypersensitivity}}. Granuloma formations. Treatment: *
Berylliosis
- Symptoms: Involves uper lobes. Carbon pigment (athracotic) accumulates in macrophages of the lympahtics and interstitium. Can result in cor pulmonale Lab Values: ↓FVC and TLC; ↑ or normal FEV1/FVC ratio (> or = 80%). Pathophysiology: Restrictive lung disease. Associated with coal mines. Particles less than 10 microns in size (escape cilia). Treatment: *
Coal miner’s pneumoconiosis
- Symptoms: {{Risk factors are prematurity, maternal diabetes (due to elevated insulin), cesarean delivery}} (decrease release of fetal glucocortiocids); risk of PDA due to low O2 tension and hemorrhage at germinal matrix. Atelectasis. Complications lead to nectrotizing enterocolitis, bronchopulmonary dysplasia, and retinal neovascularization (due to O2 treatment). Lab Values: * or = 80%).* Pathophysiology: {{Surfactant deficiency leading to incrased surface tension, resulting in alveolar collapse}}. Usually pre-35th week of gestation. Fibrin. Treatment: *Maternal steroids before birth, artifical surfactant for infant; thyroxine.
Neonatal respiratory distress syndrome
- Symptoms: Dyspnea, tachypnea, hypoxemia, cyanosis, and use of accessory respiratory muscles. Secondary to trauma, sepsis, shock, gastric aspiration, uremia, acute pancreatitis, or amniotic fluid embolism. Lab Values: {{“White out” on CXR (bilateral lung opacity).}} Protein-rich exudate in alveoli.↓FVC and TLC; {{Restrictive{{↑ or normal FEV1/FVC ratio (> or = 80%). Pathophysiology: Diffuse alveolar damage leads to increase alveolar capillary permeability.{{ Results in formation of intra-alveolar hyaline (FIBRIN) membrane. Initial damage due to release of PMN substances toxic to alveolar wall, activation of coagulation cascade, and oxygen derived free radicals.}} Treatment: *100% O2, PEEP, mechanical ventilation.
Acute respiratory distress syndrome
- Symptoms: Associated with obesity, loud snoring, systemic or pulmonary HTN, arrhythmias, and sudden death. Patient is chronically tired. Lab Values: {{Erythrocytosis (hypoxia induced EPO release)}}. Pathophysiology: Respiratory effort against airway obstruction. Person stops breathing for at least 10 seconds repeatedly during sleep. Treatment: *Weight loss, CPAP, surgery.
Obstructive sleep apnea
- Symptoms: ** Lab Values: {{Erythrocytosis (hypoxia induced EPO release).}} Pathophysiology: {{No respiratory effort. Person stops breathing for at least 10 seconds repeatedly during sleep}}. Treatment: *
Central sleep apnea
- Symptoms: ** Lab Values: {{Absent/↓ breath sounds over affected area, ↓ resonance, ↓fremitus, tracheal deviation toward side of lesion}}. Pathophysiology: ** Treatment: *
Bronchial obstruction